Publication | Closed Access

A phase IB/IIA study of ex vivo expanded allogeneic bone marrow–derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn’s disease

Regenerative MedicineMesenchymal Stem CellsCell TherapyMedicineAllogeneic BoneImmunologyStem Cell ResearchPhase Ib/iia StudyStem-cell TherapyStem Cell TherapiesBiomedical EngineeringMesenchymal Stem CellStem CellsCell TransplantationOrthopaedic Surgery